pubrio
上海津曼特生物科技有限公司

上海津曼特生物科技有限公司

China · IT Services And IT Consulting

Information Technology & Services

Pharmaceuticals

Biotechnology

Healthcare

IT Services And IT Consulting

上海津曼特生物科技有限公司 is a biopharmaceutical company engaged in the research and development of new monoclonal antibodies targeting tumor antigens and immunotherapy for multiple cancers. As the core biopharmaceutical R&D center of Shiyao Group in Shanghai, it focuses on innovative antibody drug research, key technology research for industrialization and conversion, and subsequent antibody drug production. The company aims to become a leading domestic and internationally renowned high-tech biopharmaceutical enterprise integrating R&D, conversion, and production.

Company Insights
Company Overview

2012

Founded

IT Services And IT Consulting

Industry

China

Location

23,181,609

Ranking

11 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding 上海津曼特生物科技有限公司

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​